TESOFENSINE

Tesofensine Product Description — Research Use Only

Tesofensine is a research compound studied as a triple monoamine reuptake inhibitor. It is not a peptide, but it is often grouped within peptide and research-compound catalogs because of its use in appetite, satiety, body-weight, energy-balance, and metabolic-response research.

Research on Tesofensine has most commonly focused on appetite suppression, satiety signaling, food-intake regulation, body-weight research, dopamine/norepinephrine/serotonin pathways, energy metabolism, and metabolic-response markers. Published studies describe Tesofensine as an inhibitor of presynaptic reuptake of noradrenaline, dopamine, and serotonin, which are neurotransmitter systems involved in appetite regulation and energy-balance signaling.

Tesofensine is commonly studied for:

• Appetite signaling — how hunger and food-seeking signals are regulated

• Satiety response — how fullness-related signaling is increased

• Food-intake research — pathways connected to reduced calorie intake in study models

• Body-weight research — markers connected to weight regulation and energy balance

• Dopamine pathways — how reward and motivation signaling may affect feeding behavior

• Norepinephrine pathways — how energy expenditure and alertness-related signaling are studied

• Serotonin pathways — how mood, satiety, and appetite-related signals are regulated

Tesofensine is commonly studied because it affects multiple neurotransmitter systems involved in appetite and metabolic control. In controlled research, Tesofensine has been evaluated for effects on body weight, body composition, appetite ratings, energy metabolism, and dopamine-transporter occupancy. Additional research has explored how Tesofensine may reduce food intake through indirect stimulation of α1-adrenoceptor and dopamine D1 receptor pathways.

For research use only. Not for human consumption, medical use, diagnostic use, or therapeutic application.